ADCendo company information, funding & investors | Dealroom.co
Adcendo, Duality Biologics To Further Expand First-in-Class ADC Pipeline | Contract Pharma
Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform
Adcendo and Duality Biologics sign license deal for ADC platform
Adcendo | LinkedIn
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
Leadership team | Adcendo
Duality Biologics announces license agreement with Adcendo - Medical Buyer
Carl Kilander on LinkedIn: Adcendo ApS Announces Option License Agreement with Duality Biologics to…
Ysios Capital's portfolio company Adcendo announces extension of Series A financing to 82M€ to ensure broad development of first-in-class ADC pipeline - Capital-Riesgo.es
ADCendo - Crunchbase Company Profile & Funding
Adcendo raises $61M series A round to advance uPARAP-targeting ADC candidate | BioWorld
ADCendo ApS: Trojansk kemo-behandling slår kræftceller ihjel indefra | Innovationsfonden
ADCendo - Crunchbase Company Profile & Funding
Adcendo ApS Announces Option License Agreement with Duality Biologics – Ysios Capital
Press releases | Adcendo
Adcendo Benefits From ADC Excitement To Raise More Cash :: Scrip
ADCendo - Bamdej Communication
GlyTherix and Adcendo Announce Agreement for Development of Antibody Drug Conjugate - GlyTherix
Gilde Healthcare company Adcendo Aps Announces License Agreement with Duality Biologics on Next-generation ADC Platform - Gilde Healthcare
Danish biotech startup Adcendo ApS announces extension of series A financing to €82M - ArcticStartup
Duality Biologics-Duality Biologics
ADCendo - Recent News & Activity
